GlassScriptPhysician profile
Andrew Robert Ross
NPI 1427558873
$993.14
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.83 · 2022: $374 · 2023: $538 · 2024: $19.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $169.94 | 2021-2024 | Ubrelvy, Vraylar |
| Novo Nordisk INC | $163.45 | 2021-2023 | Wegovy, Ozempic |
| Lilly USA, LLC | $119.15 | 2022-2023 | Mounjaro, Emgality, Jardiance |
| Esperion Therapeutics, INC. | $105.38 | 2021-2023 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $88.97 | 2022-2023 | Breztri, Farxiga |
| Glaxosmithkline, LLC. | $76.23 | 2022-2023 | Trelegy Ellipta |
| Idorsia Pharmaceuticals US INC | $46.00 | 2023 | Quviviq |
| Abbott Laboratories | $41.39 | 2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Exact Sciences Corporation | $33.36 | 2023 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $32.63 | 2023 | |
| Janssen Pharmaceuticals, INC | $25.47 | 2022 | |
| Organon LLC | $24.24 | 2023 | Nexplanon |
| Medtronic, INC. | $20.08 | 2022 | |
| Nestle Healthcare Nutrition INC. | $18.44 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.20 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.21 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.